financetom
Business
financetom
/
Business
/
Biogen Faces Q2 Earnings Impact Due to $46 Million Charge
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Biogen Faces Q2 Earnings Impact Due to $46 Million Charge
Jul 7, 2025 1:59 PM

04:43 PM EDT, 07/07/2025 (MT Newswires) -- Biogen (BIIB) said late Monday its Q2 GAAP and adjusted earnings could be impacted by $0.26 per diluted share due to a $46 million charge from acquired in-process research and development, as well as upfront and milestone expenses.

Biogen shares rose 1.3% during after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved